- Home
- CRVO vs NCSM Comparison
CRVO vs NCSM Comparison
Compare CRVO & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- NCSM
- Stock Information
- Founded
- CRVO 2001
- NCSM 2006
- Country
- CRVO United States
- NCSM United States
- Employees
- CRVO N/A
- NCSM N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- NCSM Oilfield Services/Equipment
- Sector
- CRVO Health Care
- NCSM Energy
- Exchange
- CRVO Nasdaq
- NCSM Nasdaq
- Market Cap
- CRVO 67.4M
- NCSM 76.3M
- IPO Year
- CRVO N/A
- NCSM 2017
- Fundamental
- Price
- CRVO $8.50
- NCSM $42.65
- Analyst Decision
- CRVO Strong Buy
- NCSM
- Analyst Count
- CRVO 6
- NCSM 0
- Target Price
- CRVO $19.17
- NCSM N/A
- AVG Volume (30 Days)
- CRVO 92.4K
- NCSM 19.9K
- Earning Date
- CRVO 11-11-2025
- NCSM 10-29-2025
- Dividend Yield
- CRVO N/A
- NCSM N/A
- EPS Growth
- CRVO N/A
- NCSM N/A
- EPS
- CRVO N/A
- NCSM 4.71
- Revenue
- CRVO $7,776,968.00
- NCSM $175,468,000.00
- Revenue This Year
- CRVO N/A
- NCSM $11.91
- Revenue Next Year
- CRVO N/A
- NCSM $7.63
- P/E Ratio
- CRVO N/A
- NCSM $8.84
- Revenue Growth
- CRVO N/A
- NCSM 19.31
- 52 Week Low
- CRVO $1.80
- NCSM $16.81
- 52 Week High
- CRVO $16.94
- NCSM $53.69
- Technical
- Relative Strength Index (RSI)
- CRVO 51.94
- NCSM 45.36
- Support Level
- CRVO $7.90
- NCSM $48.85
- Resistance Level
- CRVO $8.93
- NCSM $52.06
- Average True Range (ATR)
- CRVO 0.42
- NCSM 3.13
- MACD
- CRVO 0.06
- NCSM -1.33
- Stochastic Oscillator
- CRVO 84.30
- NCSM 15.65
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.